Universal Ibogaine Inc
XTSX:IBO
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| CA |
|
Universal Ibogaine Inc
XTSX:IBO
|
1.5m CAD |
Loading...
|
|
| CN |
|
Wenzhou Kangning Hospital Co Ltd
HKEX:2120
|
659.2m HKD |
Loading...
|
|
| CA |
|
Greenbrook TMS Inc
TSX:GTMS
|
28.6m CAD |
Loading...
|
|
| US |
|
Ethema Health Corp
OTC:GRST
|
2.3m USD |
Loading...
|
|
| US |
|
Tocca Life Holdings Inc
OTC:TLIF
|
1.3m USD |
Loading...
|
Market Distribution
| Min | -10 058.3% |
| 30th Percentile | 20.4% |
| Median | 33.6% |
| 70th Percentile | 50.5% |
| Max | 717.4% |
Other Profitability Ratios
Universal Ibogaine Inc
Glance View
Universal Ibogaine, Inc. develops ibogaine based drug franchise to treat addiction and related mental health issues. The company is headquartered in Calgary, Alberta. The company went IPO on 2017-06-21. The firm is focused on developing medicines and building a network of holistic recovery clinics for the treatment of addictions. The company treats addictions primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. Its focuses on developing ibogaine for the treatment of opioid use disorders. Ibogaine is a neuroactive compound, which is derived from various plants. Ibogaine helps to repair damaged brain tissues of the patients and helps them to recover and rebuild their lives.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Universal Ibogaine Inc is 17.3%, which is below its 3-year median of 19.2%.
Over the last 1 years, Universal Ibogaine Inc’s Gross Margin has decreased from 28.3% to 17.3%. During this period, it reached a low of 10% on Jan 31, 2025 and a high of 28.3% on Mar 30, 2024.
